Schnelldorf Facility Upgrade: Merck Boosts Life Science Distribution Capacity

Schnelldorf Facility Upgrade: Merck Boosts Life Science Distribution Capacity

(IN BRIEF) Merck, a leading science and technology company, has inaugurated its expanded Life Science distribution center in Schnelldorf, Germany, following a €180 million investment that nearly doubled its size to 25,000 square meters. The upgraded facility now includes manual down filling operations and expanded distribution space, empowering Merck to efficiently supply laboratories and research facilities worldwide. Matthias Heinzel, Member of the Executive Board and CEO of Life Science at Merck, emphasized the significance of these enhancements in expediting the delivery of critical medicines. Ivan Donzelot, Head of Integrated Supply Chain Operations, underscored the strategic importance of the Schnelldorf site as a flagship hub offering end-to-end capabilities for Life Science customers, reflecting Merck’s commitment to innovation and public health advancement.

(PRESS RELEASE) DARMSTADT, 6-Jun-2024 — /EuropaWire/ — Merck, a prominent science and technology company, has unveiled its expanded Life Science distribution center in Schnelldorf, Germany, marking a significant leap forward in its capabilities. The €180 million investment has augmented the site by 25,000 square meters, effectively doubling its footprint. Among the enhancements are new manual down filling operations and increased distribution space, facilitating the global supply of a diverse array of products to laboratories and research facilities.

The expansion not only signifies Merck’s commitment to bolstering its global presence but also underscores its dedication to advancing public health through enhanced efficiency and accessibility. Matthias Heinzel, Member of the Executive Board of Merck and CEO of Life Science, highlighted the importance of these advancements in serving customers and expediting the delivery of critical medicines to patients worldwide.

Ivan Donzelot, Head of Integrated Supply Chain Operations, Life Science, emphasized the strategic significance of the Schnelldorf facility, positioning it as a key hub in Merck’s network. With its integrated manufacturing and distribution capabilities, the site is poised to deliver expedited service to customers across Europe and beyond.

This expansion is part of Merck’s broader investment program aimed at fortifying its Life Science business sector to meet the escalating global demand for essential medications. With projects spanning Europe, China, and the United States, totaling over €2 billion since 2020, Merck is reaffirming its commitment to innovation and excellence in the service of public health.

Merck’s Life Science division encompasses over 50 production and testing sites, along with 64 distribution centers worldwide, and boasts a workforce of more than 27,000 employees across 65 countries.

About Merck

Merck, a leading science and technology company, operates across life science, healthcare and electronics. Around 63,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2023, Merck generated sales of € 21 billion in 65 countries.

Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.

All Merck press releases are distributed by e-mail at the same time they become available on the Merck website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.

Media Contact:

Rachel Bloom Baglin
+49 (6151) 72-44461
rachel.bloom-baglin@merckgroup.com

SOURCE: Merck